Femtobiomed (XKRX:327610) Debt-to-Asset : 0.05 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Femtobiomed Debt-to-Asset?

Femtobiomed's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩154.1 Mil. Femtobiomed's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩33.1 Mil. Femtobiomed's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩3,548.7 Mil. Femtobiomed's debt to asset for the quarter that ended in Dec. 2024 was 0.05.

Femtobiomed Debt-to-Asset Historical Data

The historical data trend for Femtobiomed's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Femtobiomed Debt-to-Asset Chart

Femtobiomed Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.27

0.08

0.07

0.09

0.05

Femtobiomed Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Debt-to-Asset	Get a 7-Day Free Trial			0.27	0.08	0.07	0.09	0.05

Competitive Comparison of Femtobiomed's Debt-to-Asset

For the Biotechnology subindustry, Femtobiomed's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Femtobiomed's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Femtobiomed's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Femtobiomed's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Femtobiomed Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Femtobiomed's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(154.142	+	33.07)	/	3548.666
	=	0.05

Femtobiomed's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(154.142	+	33.07)	/	3548.666
	=	0.05

Femtobiomed (XKRX:327610) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Femtobiomed Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Femtobiomed's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Femtobiomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Femtobiomed Inc (XKRX:327610) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Pangyo-ro 228 (ibaegisippal) beo, Sampyeong-dong, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13487

Website

https://www.femtobiomed.com

Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.

Femtobiomed Headlines

No Headlines